Boffin Biotech Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 24-10-2024
- Paid Up Capital ₹ 4.05 M
as on 24-10-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.70 Cr
as on 24-10-2024
- Revenue -44.31%
(FY 2023)
- Profit -81.32%
(FY 2023)
- Ebitda -33.77%
(FY 2023)
- Net Worth 1.76%
(FY 2023)
- Total Assets -8.09%
(FY 2023)
About Boffin Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 4.05 M.
The company currently has active open charges totaling ₹1.70 Cr.
Goutham Kethamal and Gouthamchand Nahata serve as directors at the Company.
- CIN/LLPIN
U24231HR2005PTC035750
- Company No.
035750
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationHaryana, Haryana
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Boffin Biotech Private Limited offer?
Boffin Biotech Private Limited offers a wide range of products and services, including Common Disease Medicines, Cough Syrup, Face Cream, Anti Marks Cream, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Antibiotic Tablets & Capsules, Cefuroxime Axetil Tablets, Aceclofenac Tablet, Aceclofenac Paracetamol Tablet.
Who are the key members and board of directors at Boffin Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Goutham Kethamal  | Director | 01-Jun-2005 | Current |
| Gouthamchand Nahata | Director | 16-Aug-2014 | Current |
Financial Performance of Boffin Biotech.
Boffin Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.31% decrease. The company also saw a substantial fall in profitability, with a 81.32% decrease in profit. The company's net worth moved up by a moderate rise of 1.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Boffin Biotech?
Unlock access to Boffin Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Member Secretary Single Window Clearance Agency Paonta Sahib Creation Date: 23 Oct 2009 | ₹1.49 M | Open |
Oriental Bank Of Commerce Creation Date: 26 May 2007 | ₹9.50 M | Open |
Oriental Bank Of Commerce Creation Date: 26 May 2007 | ₹6.00 M | Open |
How Many Employees Work at Boffin Biotech?
Boffin Biotech has a workforce of 10 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Boffin Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Boffin Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
